From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BREAKING: More ouzo for the Sheriff as £250m con Dev Clever goes bust

By Tom Winnifrith | Monday 14 August 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


There were some share promoters who pushed Dev Clever (DEV), which IPO'd at 1p, as being worth 50p per share and indeed the shares reached the 40s and were suspended at just over 30p making this a £250 million disaster waiting to happen. I pointed out that it was run from a lock up in Stafford, that it was a cash guzzling POS, the stinky share sales by the CEO ahead of a lack of profits warnings, spoof investments at a premium to the share price made by companies with no cash. My list of exposes was a long one as you can see HERE. This was always going to be a disaster but natch, mug punters knew otherwise.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:31:20